An RFA-induced transient abscopal immune activation and PD-L1 induction was observed in a CT26 mouse tumour model with combined RFA and anti-PD-1 antibody treatment showing synergistic T-cell mediated systemic immunity (149). This evidence concerns the gene PDCD1 and neoplasm.